Health economics, injecting drug users, blood-borne viruses, HIV, Theileria Annulata, hepatitis B, hepatitis C
Having joined the health economics department in August 2010, Andrew’s work is now focused more on the health economics component of a number of projects. Currently he is working on an economic evaluation of alternative approaches to testing the sentinel lymph node status in vulval cancer, and an economic evaluation focused on colorectal cancer. Previously he has undertaken cost effectiveness studies that have focused on prison interventions (see below).
Andrew has developed both a deterministic and stochastic model to describe the transmission dynamics of Theileria Annulata an often fatal tick-borne disease of cattle. This MRC funded project was in collaboration with groups in Tunisia and Turkey, areas in which the disease is particularly prevalent. This research has provided an insight into the most effective interventions that farmers can use to target ticks and reduce the potential transmission of T. annulata within their herds.
Injecting Drug Users
Andrew has undertaken a wider variety of research studies that have focused on the injecting drug user population:
Prison based interventions
Andrew has conducted research to investigate the impact of a variety of interventions that target injecting drug users in a prison setting. These have included hepatitis B vaccination on reception into prison, case finding on reception into prison for injecting drug users infected by hepatitis C, and the cost effectiveness of delivering hepatitis C screening and treatment in a prison setting.
Characteristics of the injecting drug user population
Andrew has also undertaken research to gain a better understanding of the injecting drug user population, including trying to gain a greater insight into the rate that injectors start and stop using drugs, and the impact of assumptions regarding the contact between injectors that may lead to the transmission of HIV infection